Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • News

U.S. Medicare Director Says Will Rank Top 10 Medicare Part D Drugs By Cost To Determine List For Negotiation Under IRA

By Happy Mohamed
Today, 3:26 PM
- Reuters

IYH

Read More
1 minute read
  • Biotech
  • General
  • Health Care

In 2023, Biden-Harris Administration Will Begin Negotiation Process To Lower Drug Prices For People With Medicare

By Bill Haddad
Today, 3:26 PM
-Reuters

IYH

Read More
1 minute read
  • General
  • News
  • Politics

US President Formally Signs Executive Order Directing Federal Agencies ‘to do everything in their power to expand healthcare coverage’

By Benzinga Newsdesk
Today, 3:26 PM
https://twitter.com/W7VOA/status/1511408970317144065

IYH

Read More
1 minute read
  • General
  • Health Care

‘House Democrats find in three-year investigation that drug prices are ‘unsustainable, unjustifiable and unfair” -Washington Post

By Bill Haddad
Today, 3:26 PM
https://www.washingtonpost.com/health/2021/12/10/house-democrats-find-three-ye

GILD

Read More
1 minute read
  • Biotech
  • Education
  • General
  • News

Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19

By Vandana Singh
Today, 3:26 PM
The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 for mild or sev

IHF

Read More
1 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • News

UK Rolls Out COVID-19 Antibody Tests For All: What You Need To Know

By Vandana Singh
Today, 3:26 PM
On Sunday, the U.K. government rolled out a new nationwide antibody surveillance program, in which anyone over 18 years can opt-in when having a PCR test from Tuesday. 

IXJ

Read More
1 minute read
  • Media
  • Trading Ideas

‘Fast Money Halftime Report’ Picks For August 4

By Craig Jones
Today, 3:26 PM
On CNBC's "Fast Money Halftime Report," Liz Young picked iShares US Healthcare ETF (NYSE: IYH) as her final trade on Wednesday. She likes it because it is not definitively a growth or value place.

IYH

Read More
1 minute read
  • General
  • Health Care
  • Politics

Biden Admin. To Give Hospitals More Time To Spend COVID-19 Relief Money

By Benzinga Newsdesk
Today, 3:26 PM
-Dow Jones

IYH

Read More
1 minute read
  • General
  • Health Care
  • Politics

‘No Obamacare ruling today. The court issued one opinions relating to the Armed Career Criminal Act’ -Tweet From Bloomberg Law Reporter

By Benzinga Newsdesk
Today, 3:26 PM
https://twitter.com/WheelerLydia/status/1402989730522755085

IYH

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service